Clinical Trial Update: Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 safety study of TAK-128 in subjects with diabetic peripheral neuropathy has been terminated; no specific results are provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• TAK-128

Snippet

Sponsor: Takeda | Conditions: Diabetic Neuropathies | Phase 2 | Status: TERMINATED